Author Correction: Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation (Nature Genetics, (2007), 39, 1, (99-105), 10.1038/ng1937);Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation

Nature Genetics

Volumn 39, Issue 1, 2007, Pages 99-105

  Choudhury, Aaheli Roy ^a   Ju, Zhenyu ^a   Djojosubroto, Meta W ^a   Schienke, Andrea ^a   Lechel, Andre ^a   Schaetzlein, Sonja ^a   Jiang, Hong ^a   Stepczynska, Anna ^a,b   Wang, Chunfang ^c   Buer, Jan ^a,b   Lee, Han Woong ^d   Von Zglinicki, Thomas ^c   Ganser, Arnold ^e   Schirmacher, Peter ^f   Nakauchi, Hiromitsu ^g   Rudolph, K Lenhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Yonsei University   (South Korea)

^e Department of Hematology and Oncology ^*  (Germany)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL FUNCTION; CELL POPULATION; CELL RENEWAL; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; EMBRYO; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; INTESTINE EPITHELIUM; LIFESPAN; LONGEVITY; LYMPHOPOIESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEM CELL; TELOMERE;

EID: 33845892109     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/s41588-020-0593-6     Document Type: Erratum

References (30)

1. Wright, W.E. & Shay, J.W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 383-389 (1992).
2. Allsopp, R.C. et al. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA 89, 10114-10118 (1992).
3. d'Ad da di Fagagna, F. et al. A DNA damage checkpoint response in telomere-initiated senescence. Nature 426, 194-198 (2003).
4. Brown, J.P., Wei, W. & Sedivy, J.M. Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277, 831-834 (1997).
5. Herbig, U., Jobling, W.A., Chen, B.P., Chen, D.J. & Sedivy, J.M. Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). Mol. Cell 14, 501-513 (2004).
6. Vulliamy, T. et al. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC. Nat. Genet. 36, 447-449 (2004).
7. Rudolph, K.L. et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712 (1999).
8. Herrera, E. et al. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960 (1999).
9. Hao, L.Y. et al. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123, 1121-1131 (2005).
10. Lombard, D.B. et al. DNA repair, genome stability, and aging. Cell 120, 497-512 (2005).
11. Lieber, M.R. & Karanjawala, Z.E. Aging, repetitive genomes and DNA damage. Nat. Rev. Mol. Cell Biol. 5, 69-75 (2004).
12. Min, H., Montecino-Rodriguez, E. & Dorshkind, K. Effects of aging on early B- and T-cell development. Immunol. Rev. 205, 7-17 (2005).
13. Lipschitz, D.A., Udupa, K.B., Milton, K.Y. & Thompson, C.O. Effect of age on hematopoiesis in man. Blood 63, 502-509 (1984).
14. Nishimura, E.K., Granter, S.R. & Fisher, D.E. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche. Science 307, 720-724 (2005).
15. Wagers, A.J. & Conboy, I.M. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 122, 659-667 (2005).
16. Lechel, A. et al. The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo. EMBO Rep. 6, 275-281 (2005).
17. Lee, H.W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574 (1998).
18. Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527-538 (1999).
19. Artandi, S.E. et al. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406, 641-645 (2000).
20. Blasco, M.A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34 (1997).
21. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675-684 (1995).
22. Hemann, M.T., Strong, M.A., Hao, L.Y. & Greider, C.W. The shortest telomere, not average telomere length, is critical for cell viability and chromosomal stability. Cell 107, 67-77 (2001).
23. Sudo, K., Ema, H., Morita, Y. & Nakauchi, H. Age associated characteristics of murine haematopoietic stem cells. J. Exp. Med. 192, 1273-1280 (2000).
24. Cheng, T. et al. Haematopoeitic stem cell quiescence maintained by p21Waf1/Cip1. Science 287, 1804-1808 (2000).
25. Rudolph, K.L. et al. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155-159 (2001).
26. Greenberg, R.A. et al. Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97, 515-525 (1999).
27. Carnero, A. & Beach, D.H. Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. Oncogene 23, 6006-6011 (2004).
28. Prowse, K.R. & Greider, C.W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822 (1995).
29. Randall, T.D. & Weissman, I.L. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population? Stem Cells 16, 38-48 (1998).
30. Satyanarayana, A. et al. Telomere shortening impairs organ regeneration by inhibiting cell cycle re-entry of a subpopulation of cells. EMBO J. 22, 4003-4013 (2003).